All In MedTech

Device Trial Radar · NCT07947186

Early Feasibility Study of a Novel Male Contraceptive Device: Safety, Usability, and Acceptability Outcomes

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Oct 19, 2026

Primary completion

Apr 19, 2027

Study completion Apr 19, 2027

Sponsor

Lead sponsor
Indiana UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 18, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a Phase 1 feasibility study evaluating the safety, barrier efficacy, and user acceptability of a novel male contraceptive device, the Galactic Cap (GC), an adhesive, polyurethane-based barrier designed to cover the glans penis. Unlike traditional condoms, the device adheres directly to the penile surface to improve fit, reduce slippage, and enhance sensation through increased skin-to-skin contact and improved heat transfer. The study will enroll 40 monogamous heterosexual couples in which the male partner has undergone vasectomy, allowing assessment of device performance independent of pregnancy risk. Participants will use the device during four separate acts of vaginal intercourse over approximately one month, with data collected via genital examinations, participant diaries, post-use surveys, and pre- and post-coital vaginal swabs analyzed for prostate-specific antigen (PSA) to assess semen leakage. The primary objective is to evaluate safety, with secondary assessment of barrier effectiveness and exploratory evaluation of device performance and user satisfaction compared to traditional condoms.

Conditions

  • Male Contraception
  • Contraceptive Device
  • Pregnancy Prevention
  • Prevention of Semen Exposure During Intercourse

Interventions

  • Galactic CapDevice

    Use galactic cap four times per week for two weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Device SafetyTime frame: Day 1 to Day 30

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Indiana University Men's Health Clinic Indiana University Health North Hospital

    Carmel, Indiana · Recruiting

  • Indiana University Men's Health Clinic Indiana University Health North Hospital

    Indianapolis, Indiana · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.